press releases

Free-to-attend event takes place at Pfizer in Cambridge, MA from 16–17 June Drug Discovery USA 2026 to focus on emerging multifunctional small molecule and biologic approaches to drug difficult targets Cambridge, UK, 14 April 2026: ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, today announced the launch of Drug Discovery USA 2026. The inaugural event, taking place at Pfizer in Cambridge, MA from 16–17 June, offers the dr

Robust DNA extraction supports earlier detection and diagnosis of colorectal cancer and other gastrointestinal diseases Manchester, UK, and Cambridge, UK, 24 March 2026:   Primerdesign (part of the Novacyt Group), a company focused on the design, manufacture, validation and supply of nucleic acid extraction and real-time PCR kits, and Origin Sciences (Origin), a company pioneering the detection and diagnosis of gastrointestinal (GI) disease through an unprecedented focus on a

Bioprocessing leader to drive continued commercial development and international expansion Cambridge, UK, and Cambridge, US, 23 March 2026: Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, today announced that it has appointed Dale Gordon as Chair of the Board of Directors. His appointment strengthens governance and board-level expertise at Abselion, adding experienced commercial and bioprocess leadership as the compa